Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited.

Details

Serval ID
serval:BIB_8E741C11DD82
Type
Article: article from journal or magazin.
Publication sub-type
Editorial
Collection
Publications
Institution
Title
Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited.
Journal
Blood pressure
Author(s)
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S.
ISSN
1651-1999 (Electronic)
ISSN-L
0803-7051
Publication state
Published
Issued date
06/2019
Peer-reviewed
Oui
Volume
28
Number
3
Pages
144-145
Language
english
Notes
Publication types: Editorial
Publication Status: ppublish
Keywords
Antibodies, Monoclonal, Humanized/therapeutic use, Anticholesteremic Agents/therapeutic use, Cardiovascular Diseases/etiology, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Cholesterol/metabolism, Clinical Trials as Topic/methods, Enzyme Inhibitors/therapeutic use, Humans, Hypertension/complications, Hypertension/drug therapy, Proprotein Convertase 9/antagonists & inhibitors, Risk Factors, Risk Reduction Behavior
Pubmed
Web of science
Open Access
Yes
Create date
03/06/2019 17:19
Last modification date
04/01/2020 7:17
Usage data